Drug-induced liver injury in clinical practice: Pharmacist as a pillar of medication safety
Hepatotoxicity is the most frequent reason for post-marketing withdrawal of medicines, yet in clinical practice drug-induced liver injury (DILI) remains a diagnosis of exclusion with no confirmatory biomarker. In the Prospective European DILI Registry, antibacterials (40%) and antineoplastic/immunomodulating agents (27...